This suggests that ANKRD17 promotes the pro-metastatic transcription of Yap1 and pro-survival AKT phosphorylation during HCC metastatic progression by dysregulating the HIPPO and PTEN signaling pathways, respectively. The gene discussed is AKT1; the disease is hepatocellular carcinoma.